Invesaro

Stocks SRL Financial statements

Financial statements

Scully Royalty Ltd. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Scully Royalty Ltd. files with the SEC in its annual reports.

In CAD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2015FY2017FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Revenue1,6291,13227414011359.471.363.754.935.3
Cost of revenue1,5741,06122895.296.626.930.929.919.17.06
Gross profit1,6291,13227414011359.471.363.754.935.3
Selling, general and administrative86.679.245.526.422.619.921.128.524.225.3
Interest expense22.324.18.422.131.241.881.941.811.762.49
Pre-tax income-291-16.7-38.4168-16.811.217.5-2410.2-19
Income tax-46.27.018.6655.61.621110.2-0.558.81.25
Income from continuing operations-245-23.7-47.1112-18.40.217.37-23.41.4-20.3
Net income to minority interests-1.63-1.64-0.790.07-0.150.160.190.01-0.01-0.32
Net income-488-25.4-47.9112-18.60.377.56-23.41.39-20.6
EPS, basic-32.87-1.71-3.247.63-1.260.030.51-1.580.09-1.39
EPS, diluted-32.87-1.71-3.247.63-1.260.030.51-1.580.09-1.39

Balance sheet

FY2015FY2017FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Cash and equivalents19812174.967.878.363.654.963.778.351.8
Receivables13634.370.342.3
Inventory329.8311.42.391.411.10.841.20
Total current assets401149102108129146180165175
Property, plant and equipment95.799.48458.355.451.949.128.9
Lease right-of-use assets1.191.110.690.630.27
Total assets650397507503509510475452438
Accounts payable45.144.826.319.215.711.321.11614.8
Short-term debt95.42.07
Total current liabilities21592.827.219.916.112.34320.638.5
Lease liabilities0.830.790.480.310
Total liabilities321117113141140137143123128
Total debt11743.7035.438.135.235.536.136.5
Retained earnings-88.9-87.219.31.011.389.08-31.5-33.4-58.8
Shareholders' equity328278386354362366325322302
Minority interests1.912.178.038.47.186.937.357.218.05
Total equity369329280394362369373333330310
Total liabilities and equity650397507503509510475452438

Cash flow statement

FY2015FY2017FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Net income-486-23.7-47.1112-18.40.217.37-23.41.4-20.3
Depreciation and amortization6.45121.640.250.50.560.480.780.930.86
Cash from operations-3.2-7.19-9.81-21.3-6.6430.626.2-31.5
Capital expenditures-8.05-0.2-4.78-0.2-0.72-0.23-0.98-0.47-0.18-0.09
Cash from investing-8.5635.5-3.49-1.28-10.23.42-0.97-4.68-6.312.76
Debt issued5.6620.7
Debt repaid-68.7-186-42.3
Dividends paid-4.39-1.68-1.6-0.81-0.04-16.9-3.42-5.55
Exchange rate effect35.6-37.53.612.22-4.273.63-0.650.08-1.523.44
Net change in cash-145-69.5-45.8-7.1110.5-14.7-8.688.8414.5-26.5
Free cash flow-7.98-7.39-10.5-21.5-7.6230.226-31.6
Interest paid-15.314.54.581.20.341.881.751.561.641.72
Income taxes paid-5.35-3.32-1.7-2.63-0.78-3.73-9.53-5.88-2.98-0.34

Key metrics

Worked out from the statements above. Latest values use fiscal 2024. No valuation: the share price is quoted in a different currency than the statements.

Profitability

MetricValueHow it is calculated
Gross margin100.0%Gross profit / revenue.
Pre-tax margin-53.9%Pre-tax income / revenue.
Net margin-58.3%Net income / revenue.
FCF margin-89.6%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-89.4%Cash from operations / revenue.
Return on equity (ROE)-6.6%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-4.6%Net income / average total assets.
SG&A / revenue71.8%Selling, general and administrative expense / revenue.
Capex / revenue0.3%Capital expenditures / revenue.
D&A / revenue2.4%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-35.7%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-20.9%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y-20.8%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-35.7%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-20.9%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y-20.8%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-1,580.0%Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y-1,644.0%EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y-220.5%Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y-221.7%Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y-6.3%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-6.1%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-3.1%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-3.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-4.9%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-2.7%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.

Balance sheet health

MetricValueHow it is calculated
Current ratio4.56xCurrent assets / current liabilities.
Quick ratio2.44x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio1.34x(Cash + short-term investments) / current liabilities.
Debt / equity0.12xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets8.3%Total debt / total assets.
Liabilities / assets29.2%Total liabilities / total assets.
Net debt-CA$15.2MTotal debt - cash - short-term investments. Negative means more cash than debt.
Working capitalCA$136.8MCurrent assets - current liabilities.
Tangible book valueCA$302.3MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.08xRevenue / average total assets.
Inventory turnover11.8xCost of revenue / average inventory.
Days inventory31 days365 x average inventory / cost of revenue.
Receivables turnover0.63xRevenue / average receivables.
Days sales outstanding582 days365 x average receivables / revenue.
Days payables797 days365 x average accounts payable / cost of revenue.
Cash conversion cycle-184 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted-CA$1.39Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic-CA$1.39Net income per basic share, as reported (split-adjusted).
What was Scully Royalty Ltd.'s revenue in fiscal 2024?

Scully Royalty Ltd. reported revenue of CA$35.3M for fiscal 2024, 35.7% lower than the year before.

Was Scully Royalty Ltd. profitable in fiscal 2024?

No. It reported a net loss of CA$20.6M.

How much free cash flow did Scully Royalty Ltd. generate in fiscal 2024?

Cash from operations of CA$31.5M minus capital expenditures of CA$89.0K left free cash flow of -CA$31.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Scully Royalty Ltd.